Lv417
630 积分 2024-04-13 加入
Site-specific ubiquitylation and SUMOylation using genetic-code expansion and sortase
1天前
已完结
Right ON target: a new RAS-GTP inhibitor
8天前
已完结
Targeting Oncogenic RAS Protein
8天前
已完结
A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor
10天前
已完结
Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directions
10天前
已完结
Annual review of PROTAC degraders as anticancer agents in 2022
10天前
已完结
Discovery of a Potent Dual Son of Sevenless 1 (SOS1) and Epidermal Growth Factor Receptor (EGFR) Inhibitor for the Treatment of Prostate Cancer
10天前
已完结
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRAS G12D inhibitor in KRAS LUAD
11天前
已完结
Discovery of Orally Bioavailable SOS1 Inhibitors for Suppressing KRAS-Driven Carcinoma
11天前
已完结
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery
11天前
已完结
皖公网安备34019202002308
